Compass Therapeutics (CMPX) EPS (Basic) (2018 - 2026)
Compass Therapeutics' (CMPX) quarterly EPS (Basic) came in at -$0.1 in Q1 2026, up 16.67% year-on-year from -$0.09 in Q1 2025, and down 25.0% quarter-over-quarter from -$0.08 in Q4 2025.
Compass Therapeutics (CMPX) EPS (Basic) (2018 - 2026) Analysis & Trends
Compass Therapeutics has disclosed EPS (Basic) across 9 years of filings, most recently posting -$0.1 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.1, up 16.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.4 (up 2.44% YoY), and the FY2025 annual result was -$0.42, down 16.67% from the prior year.
- EPS (Basic) came in at -$0.1 for Q1 2026 at Compass Therapeutics, down from -$0.08 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.06 in Q1 2023 to a low of -$0.14 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.09 (2023), against an average of -$0.09.
- Peak annual rise in EPS (Basic) reached 50.0% in 2022, while the deepest fall reached 100.0% in 2022.
- Compass Therapeutics' EPS (Basic) stood at -$0.1 in 2022, then fell by 0.0% to -$0.1 in 2023, then fell by 10.0% to -$0.11 in 2024, then grew by 27.27% to -$0.08 in 2025, then slipped by 25.0% to -$0.1 in 2026.
- The last three EPS (Basic) figures came in at -$0.1 (Q1 2026), -$0.08 (Q4 2025), and -$0.08 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Compass Therapeutics | 387.71 Mn | 193.02 Mn | - | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.08 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.12 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.10 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.06 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.08 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.10 |
| Mar 31, 2021 | -0.14 |